Cargando…
Anti-SARS-CoV-2 Vaccines and Monoclonal Antibodies Facing Viral Variants
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is genetically variable, allowing it to adapt to various hosts including humans. Indeed, SARS-CoV-2 has accumulated around two mutations per genome each month. The first relevant event in this context was the occurrence of the mutant D...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234553/ https://www.ncbi.nlm.nih.gov/pubmed/34207378 http://dx.doi.org/10.3390/v13061171 |